CAS 2374782-03-1

Fórmula: C36H47F2N9O8

InChI: InChI=1S/C36H47F2N9O8/c37-36(38)19-26(20-39)47(25-36)31(48)21-41-35(54)28-4-5-40-30-3-2-27(18-29(28)30)55-17-1-6-42-13-15-46(16-14-42)32(49)22-43-7-9-44(23-33(50)51)11-12-45(10-8-43)24-34(52)53/h2-5,18,26H,1,6-17,19,21-25H2,(H,41,54)(H,50,51)(H,52,53)/t26-/m0/s1

Clave InChI: XQARGGQZFNOLDH-SANMLTNESA-N

SMILES: C1CN(CCN1CCCOC2=CC3=C(C=CN=C3C=C2)C(=O)NCC(=O)N4CC(C[C@H]4C#N)(F)F)C(=O)CN5CCN(CCN(CC5)CC(=O)O)CC(=O)O

(S)-2,2'-(7-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid

CAS: 2374782-03-1

(S)-2,2'-(7-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid

Fórmula: C₃₆H₄₇F₂N₉O₈

Pureza: 98%

Peso molecular: 771.82

Ref: 54-PC1006414

(S)-2,2'-(7-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid

CAS: 2374782-03-1

Fórmula: C₃₆H₄₇F₂N₉O₈

Pureza: 98%

Peso molecular: 771.8107

Ref: IN-DA0249QO

NOTA-FAPI

CAS: 2374782-03-1

(S)-2,2'-(7-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid

Fórmula: C₃₆H₄₇F₂N₉O₈

Pureza: 98%

Peso molecular: 771.81

Ref: IN-DG01263181

NOTA-FAPI

CAS: 2374782-03-1

NOTA-FAPI is a FAP inhibitor and FAPI-4 analogue used in PET imaging and targeted therapy for FAP-overexpressing pathological conditions.

Fórmula: C₃₆H₄₇F₂N₉O₈

Pureza: 99.74%

Forma y color: Yellow Solid

Peso molecular: 771.81

Ref: TM-T69660